Terms: = Brain cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
200 results:
1. Air quality and cancer risk in the All of Us Research Program.
Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
[TBL] [Abstract] [Full Text] [Related]
2. Integration of datasets for individual prediction of DNA methylation-based biomarkers.
Merzbacher C; Ryan B; Goldsborough T; Hillary RF; Campbell A; Murphy L; McIntosh AM; Liewald D; Harris SE; McRae AF; Cox SR; Cannings TI; Vallejos CA; McCartney DL; Marioni RE
Genome Biol; 2023 Dec; 24(1):278. PubMed ID: 38053194
[TBL] [Abstract] [Full Text] [Related]
3. Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer.
Englisch C; Moik F; Thaler J; Koder S; Mackman N; Preusser M; Pabinger I; Ay C
Haematologica; 2024 Apr; 109(4):1128-1136. PubMed ID: 37822244
[TBL] [Abstract] [Full Text] [Related]
4. Identification of immune-related hub genes and construction of an immune-related gene prognostic index for low-grade glioma.
Zhou J; Guo H; Liu L; Jin Z; Zhang W; Tang T
J Cell Mol Med; 2023 Dec; 27(23):3851-3863. PubMed ID: 37775993
[TBL] [Abstract] [Full Text] [Related]
5. A Syx-rhoa-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma.
Lin WH; Feathers RW; Cooper LM; Lewis-Tuffin LJ; Chen J; Sarkaria JN; Anastasiadis PZ
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427593
[TBL] [Abstract] [Full Text] [Related]
6. miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma.
Hanif F; Zhang Y; Dube C; Gibert MK; Saha S; Hudson K; Marcinkiewicz P; Kefas B; Guessous F; Abounader R
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298284
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative Laboratory Values Are Predictive of Adverse Postoperative Outcomes in Patients Older Than 65 Years Undergoing brain Tumor Resection: A National Surgical Quality Improvement Program Study.
Varela S; Puentes H; Moya A; Kazim SF; Couldwell WT; Schmidt MH; Bowers CA
World Neurosurg; 2023 Aug; 176():e49-e59. PubMed ID: 36972900
[TBL] [Abstract] [Full Text] [Related]
8. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.
Gill H; Raghupathy R; Lee CYY; Yung Y; Chu HT; Ni MY; Xiao X; Flores FP; Yim R; Lee P; Chin L; Li VWK; Au L; Au WY; Ma ESK; Mohan D; Kumana CR; Kwong YL
BMC Cancer; 2023 Feb; 23(1):141. PubMed ID: 36765318
[TBL] [Abstract] [Full Text] [Related]
9. Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors.
Ma S; Patell R; Miller E; Ren S; Marquez-Garcia J; Panoff S; Sharma R; Pinson A; Elavalakanar P; Weber G; Uhlmann E; Neuberg D; Soman S; Zwicker JI
J Thromb Haemost; 2023 May; 21(5):1148-1155. PubMed ID: 36740041
[TBL] [Abstract] [Full Text] [Related]
10. Infiltrating gliomas with FGFR alterations: Histologic features, genetic alterations, and potential clinical implications.
Dono A; El Achi H; Bundrant BE; Goli PS; Zhu P; Ozkizilkaya HI; Esquenazi Y; Ballester LY
Cancer Biomark; 2023; 36(2):117-131. PubMed ID: 36530080
[TBL] [Abstract] [Full Text] [Related]
11. brain metastatic outgrowth and osimertinib resistance are potentiated by rhoa in EGFR-mutant lung cancer.
Adua SJ; Arnal-Estapé A; Zhao M; Qi B; Liu ZZ; Kravitz C; Hulme H; Strittmatter N; López-Giráldez F; Chande S; Albert AE; Melnick MA; Hu B; Politi K; Chiang V; Colclough N; Goodwin RJA; Cross D; Smith P; Nguyen DX
Nat Commun; 2022 Dec; 13(1):7690. PubMed ID: 36509758
[TBL] [Abstract] [Full Text] [Related]
12. High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI.
Gamboa NT; Crabb B; Henson JC; Cole KL; Weaver BD; Karsy M; Jensen RL
J Neurooncol; 2022 Dec; 160(3):555-565. PubMed ID: 36394718
[TBL] [Abstract] [Full Text] [Related]
13. The Bile Acid Membrane Receptor TGR5 in cancer: Friend or Foe?
Qi Y; Duan G; Wei D; Zhao C; Ma Y
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014536
[TBL] [Abstract] [Full Text] [Related]
14. Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration.
Porcù E; Maule F; Manfreda L; Mariotto E; Bresolin S; Cani A; Bortolozzi R; Della Puppa A; Corallo D; Viola G; Rampazzo E; Persano L
Transl Res; 2023 Jan; 251():41-53. PubMed ID: 35788055
[TBL] [Abstract] [Full Text] [Related]
15. Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/rhoa signaling.
Chen B; Wang M; Qiu J; Liao K; Zhang W; Lv Q; Ma C; Qian Z; Shi Z; Liang R; Lin Y; Ye J; Qiu Y; Lin Y
J Exp Clin Cancer Res; 2022 Jun; 41(1):209. PubMed ID: 35765111
[TBL] [Abstract] [Full Text] [Related]
16. Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma.
Liu Y; Xu X; Zhang Y; Mo Y; Sun X; Shu L; Ke Y
Cell Death Dis; 2022 Jun; 13(6):536. PubMed ID: 35676251
[TBL] [Abstract] [Full Text] [Related]
17. Usefulness of Wave-CAIPI for Postcontrast 3D T1-SPACE in the Evaluation of brain Metastases.
Baek HJ; Heo YJ; Kim D; Yun SY; Baek JW; Jeong HW; Choo HJ; Lee JY; Oh SI
AJNR Am J Neuroradiol; 2022 Jun; 43(6):857-863. PubMed ID: 35618423
[TBL] [Abstract] [Full Text] [Related]
18. Dematin inhibits glioblastoma malignancy through rhoa-mediated CDKs downregulation and cytoskeleton remodeling.
Wang M; Chen B; Zhang W; Zhang F; Qiu Y; Lin Y; Yang S
Exp Cell Res; 2022 Aug; 417(1):113196. PubMed ID: 35561787
[TBL] [Abstract] [Full Text] [Related]
19. BKM120 alters the migration of doublecortin-positive cells in the dentate gyrus of mice.
Hwang Y; Kim HC; Shin EJ
Pharmacol Res; 2022 May; 179():106226. PubMed ID: 35460881
[TBL] [Abstract] [Full Text] [Related]
20. Lovastatin Inhibits rhoa to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon cancer.
Xiao Y; Liu Q; Peng N; Li Y; Qiu D; Yang T; Kang R; Usmani A; Amadasu E; Borlongan CV; Yu G
Cell Transplant; 2022; 31():9636897221075749. PubMed ID: 35168393
[TBL] [Abstract] [Full Text] [Related]
[Next]
